Literature DB >> 35158001

Disorders of Hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.

Dayoung Ko1, Rebecca F Wang1, David Ozog1, Henry W Lim1, Tasneem F Mohammad2.   

Abstract

Key challenges in the management of pigmentary disorders such as melasma and post-inflammatory hyperpigmentation (PIH) are their resistance to treatment, tendency to recur after treatment, and the risk of exacerbating hyperpigmentation with many treatment modalities. The second article in this two-part continuing medical education series on pigmentary disorders focuses on the evidence behind medical and procedural treatments of dyschromias, including photoprotection, topical lightening agents, oral agents, chemical peels, and laser therapy.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  ablative fractionated lasers; chemical peels; hydroquinone; intense pulsed light; lasers; lightening cosmeceuticals; melasma; non-ablative fractionated lasers; oral lightening agents; photoprotection; picosecond lasers; pigmentary disorders; post-inflammatory hyperpigmentation; q-switched lasers; sunscreen; topical lightening agents

Year:  2022        PMID: 35158001     DOI: 10.1016/j.jaad.2021.12.065

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  1 in total

Review 1.  The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review.

Authors:  Yeon Seok Lee; Yu Jin Lee; Jung Min Lee; Tae Young Han; June Hyunkyung Lee; Jae Eun Choi
Journal:  Medicina (Kaunas)       Date:  2022-07-14       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.